Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-012228
Filing Date
2024-08-14
Accepted
2024-08-14 16:07:03
Documents
81
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q zom-20240630x10q.htm   iXBRL 10-Q 2028155
2 EX-10.3 zom-20240630xex10d3.htm EX-10.3 93085
3 EX-10.4 zom-20240630xex10d4.htm EX-10.4 75712
4 EX-31.1 zom-20240630xex31d1.htm EX-31.1 11844
5 EX-31.2 zom-20240630xex31d2.htm EX-31.2 12644
6 EX-32.1 zom-20240630xex32d1.htm EX-32.1 11085
  Complete submission text file 0001558370-24-012228.txt   10238153

Data Files

Seq Description Document Type Size
7 EX-101.SCH zom-20240630.xsd EX-101.SCH 45009
8 EX-101.CAL zom-20240630_cal.xml EX-101.CAL 76329
9 EX-101.DEF zom-20240630_def.xml EX-101.DEF 166793
10 EX-101.LAB zom-20240630_lab.xml EX-101.LAB 442367
11 EX-101.PRE zom-20240630_pre.xml EX-101.PRE 334785
84 EXTRACTED XBRL INSTANCE DOCUMENT zom-20240630x10q_htm.xml XML 2494436
Mailing Address 100 PHOENIX DRIVE SUITE 125 ANN ARBOR MI 48108
Business Address 100 PHOENIX DRIVE SUITE 125 ANN ARBOR MI 48108 (734) 369-2555
Zomedica Corp. (Filer) CIK: 0001684144 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38298 | Film No.: 241207623
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)